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F1F0-ATP synthase inhibitory factor 1 (IF1) inhibits the reverse mode of F1F0-ATP
synthase, and therefore protects cellular ATP content at the expense of accelerated
loss of mitochondrial membrane potential (19m). There is considerable variability in IF1
expression and its influence on bioenergetics between different cell types. High levels of
IF1 in a number of cancers have been linked to increased glycolysis, resistance to cell
death, increased migration and proliferation. However, neither the expression nor role of
IF1 in the normal pancreas or in pancreatic cancer has been characterized. In this study,
we found that pancreatic ductal adenocarcinoma (PDAC) patients express higher levels
of IF1 in cancerous cells than in pancreatic acinar cells (PACs). PDAC cell lines have a
higher IF1 content and IF1/ATP synthase ratio than PACs. The observed differences are
consistent with the ability of the respective cell types to maintain 19m and ATP levels
in conditions of chemical hypoxia. Acinar cells and PDAC cells preferentially express
different IF1 isoforms. Both knockdown and knockout of IF1 in the PANC-1 pancreatic
cancer cell line modified cellular bioenergetics and decreased migration, invasion and
proliferation suggesting the putative importance of IF1 for PDAC growth and metastasis.
Keywords: pancreatic ductal adenocarcinoma, pancreatic acinar cells, F1F0-ATP synthase inhibitory factor 1,
bioenergetics, ATP, mitochondrial membrane potential
INTRODUCTION
F1F0-ATP synthase inhibitory factor 1 is a small, heat stable protein capable of interacting with
F1F0-ATP synthase (Pullman and Monroy, 1963; Cabezon et al., 2000b; Campanella et al., 2008).
The F1F0-ATP synthase plays a major role in OXPHOS and is the main ATP producing enzyme
in the majority of mammalian cells [reviewed in (Walker, 2013)]. ATP synthesis by F1F0-ATP
Abbreviations: 19m, mitochondrial membrane potential; ATPsβ, β subunit of F1F0-ATP synthase; CCCP, carbonyl
cyanide m-chlorophenyl hydrazone; ETC, electron transport chain; HPDE cells, human pancreatic ductal epithelial cells;
IEX-1, immediate early gene X-1; IF1, F1F0-ATP synthase inhibitory factor 1 also known as ATP synthase inhibitory factor
1; OXPHOS, oxidative phosphorylation; PDAC, pancreatic ductal adenocarcinoma; TMRM, tetramethyl rhodamine methyl
ester.
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synthase is coupled to H+ transfer via its F0 domain and requires
a significant electrochemical gradient, formed by the respiratory
complexes of the ETC (Walker, 2013). Under conditions
in which mitochondrial respiration is compromised, such as
during oxygen deprivation (e.g., as a result of ischemia), the
electrochemical gradient collapses and it becomes energetically
favorable for the F1F0-ATP synthase to work in reverse as
an ATP-hydrolysing proton pump (Green and Grover, 2000;
Vinogradov, 2000; Campanella et al., 2008). This reverse mode
can sustain the 1ψm, but is coupled to undesirable hydrolysis of
ATP (Campanella et al., 2008). In some cell types approximately
80–90% of ATP consumption during ischaemic conditions has
been attributed to hydrolysis by the F1F0-ATP synthase (Rouslin
et al., 1990; Di Pancrazio et al., 2004). Mitochondrial ATP
consumption can lead to cell death, especially in metabolically
active tissues that do not have a high glycolytic capacity (Jennings
and Reimer, 1991; Grover et al., 2008).
Hydrolysis of ATP by F1F0-ATP synthase is inhibited by IF1
(Pullman and Monroy, 1963; Cabezon et al., 2000b) a highly
conserved protein, encoded by the ATPIF1 gene (Ichikawa et al.,
1999; Martinez-Reyes and Cuezva, 2014). Variable splicing of
the IF1 mRNA results in IF1 isoforms 1, 2 and 3 [reviewed
in (Garcia-Bermudez and Cuezva, 2016)]. IF1 binds to the F1
domain of F1F0-ATP synthase with a 1:1 stoichiometry, and
inhibits ATPase activity in a reversible and non-competitive
manner (Green and Grover, 2000). Inhibition of F1F0-ATP
synthase by IF1 is pH dependent; at a pH value of 6.5 or below,
IF1 is present within mitochondria in its active dimeric state
(Cabezon et al., 2000a). Optimal inhibition by IF1 is between
pH 6.5 and 6.7, a level reached in the mitochondria during
ischaemic conditions (Rouslin, 1983). At higher pH, IF1 dimers
form tetramers, a structure which masks residues 14–47 – the
inhibitory region of the protein – and therefore renders IF1
inactive (Cabezon et al., 2000a, 2001). IF1 has been shown
to decrease ATP hydrolysis by the F1F0-ATP synthase by up
to 80–90% (Rouslin et al., 1990; Garcia et al., 2006), and can
therefore considerably protect cells from ischaemic injury and
death. The level of IF1 expression naturally varies in tissues and
cell types depending on how metabolically active they are, and
therefore dictates their response to hypoxia (Campanella et al.,
2008).
F1F0-ATP synthase inhibitory factor 1 expression is
upregulated in a number of human cancers (Sanchez-Cenizo
et al., 2010; Sanchez-Arago et al., 2013; Wu et al., 2015; Yin et al.,
2015; Gao et al., 2016; Santacatterina et al., 2016). In cancer
cells, increased IF1 expression is associated with metabolic
reprogramming (Sanchez-Cenizo et al., 2010), resistance to
apoptosis (Formentini et al., 2012; Faccenda et al., 2013;
Santacatterina et al., 2016), increased invasion (Wu et al., 2015;
Yin et al., 2015) and increased proliferation (Formentini et al.,
2012; Sanchez-Arago et al., 2013; Yin et al., 2015; Santacatterina
et al., 2016). In addition, previous studies have reported that
high IF1 expression correlates with poor prognosis and reduced
survival, demonstrating its potential use as a predictive marker
(Sanchez-Arago et al., 2013; Song et al., 2014; Wu et al., 2015; Yin
et al., 2015; Gao et al., 2016). It should be noted, however, that in
a number of cancer types high IF1 was associated with increased
patient survival (Sanchez-Arago et al., 2013) and that some IF1
effects are controversial (Fujikawa et al., 2012).
Pancreatic cancer is the 7th most common cause of cancer-
related death globally (Ferlay et al., 2015) with PDAC accounting
for the majority (∼85%) of cases. Understanding the cellular
mechanisms of carcinogenesis is paramount for the development
of treatment against this type of cancer. Changes of IF1
expression during malignant transformation of the exocrine
pancreas and its effects on cellular bioenergetics, proliferation
and invasion of PDAC cells have not yet been described. This
therefore became the focus of our study.
MATERIALS AND METHODS
Chemicals
Oligomycin was purchased from Cayman Chemical;
Paraformaldehyde (16%) was obtained from Agar Scientific, and
Propidium iodide from Thermo Fisher Scientific. Antimycin,
CCCP, TMRM, Iodoacetate, Collagenase and Triton-x were all
purchased from Sigma. All chemicals used were of analytical
grade.
Cell Culture
The human pancreatic cancer cell lines, PANC-1, MIA PaCa-2
and BxPC-3 (American Type Culture Collection, CRL-1469,
CRL-1420 and CRL-1687 respectively), were cultured in complete
Dulbecco’s modified Eagle medium (DMEM) supplemented with
10% (v/v) fetal bovine serum (FBS), 100 units/ml penicillin,
100 µg/ml streptomycin and 292 µg/ml glutamine (all from
Thermo Fisher Scientific). Primary murine pancreatic cancer
cells were isolated from tumors arising in the Kras; p53; Pdx-Cre
mouse model (KPC) as previously described (Olive et al., 2009).
KPC-derived PDAC cells were cultured in complete DMEM
and used at a low passage (<10). HPDE cells were purchased
from Kerafast (Boston, MA, United States). The specific HPDE
cell line (H6c7, catalog number ECA001) was cultured in
1x Keratinocyte-SFM supplemented with human recombinant
epidermal growth factor 1-53 (EGF-153) and Bovine pituitary
extract (BPE) (Thermofisher Scientific). All cell lines were
cultured at 37◦C with 5% CO2 in a humidified incubator.
Mouse Tissue and Primary Cells
Tissues and pancreatic acinar cells (PACs) were obtained from
6-week-old, male CD1 and C57BL6/J mice (Charles River).
The animals were humanely sacrificed by cervical dislocation
(schedule 1 procedure) in accordance with the Animals
(Scientific Procedures) Act (1986) under Establishment License
40/2408 and with approval by the University of Liverpool Animal
Welfare Committee and Ethical Review Body. For isolation of
PACs, pancreata were digested using 200 unit/ml collagenase as
previously described (Osipchuk et al., 1990).
Immunofluorescence Studies
Immunofluorescence staining was performed on cells fixed with
4% Paraformaldehyde, permeabilised with 0.2% Triton-x and
blocked with 10% Goat serum and 1% Bovine Serum Albumin
Frontiers in Physiology | www.frontiersin.org 2 July 2018 | Volume 9 | Article 833
fphys-09-00833 July 9, 2018 Time: 15:29 # 3
Tanton et al. IF1 in Normal and Malignant Exocrine Pancreas
in phosphate buffered saline (PBS). The primary antibodies
used were IF1 [5E2D7] (ab110277, Abcam), IF1 (12067-1-AP,
Proteintech) and ATPsβ (ab14730, Abcam). Goat anti-mouse
(H + L) lgG (Alexa Fluor 488, A-11001 Invitrogen) and Goat
anti-rabbit (H + L) lgG (Alexa Fluor 647, A-21244 Invitrogen)
were used as secondary antibodies.
Immunohistochemistry
Formalin-fixed and paraffin-embedded PDAC tissue sections
(from 17 patients) were obtained from NIHR Liverpool Pancreas
Biomedical Research Unit (PBRU). All patients gave written
informed consent using approved ethics protocols, at the
Royal Liverpool University Hospital. The study was approved
by the National Research Ethnics Service Committee North
West- Cheshire 11/NW/0083. All procedures were performed
in accordance with the relevant guidelines and regulations.
The samples were deparaffined and underwent antigen retrieval
in a PT link (Dako). Samples were blocked with peroxidase
block solution (Dako envision kit) and incubated with IF1
(mouse 12067-1-AP, Proteintech) and ATPsβ (rabbit ab14730,
Abcam) antibodies. All samples were stained with the respective
secondary antibodies (Dako envision kit) and counterstained
with haematoxylin.
Western Blot Analysis
A Pierce BCA protein assay kit (Thermo Fisher Scientific)
was used to determine the protein concentration of lysed
samples against Bovine serum albumin standards of known
concentration. Samples containing equal amounts of protein
were electrophoresed on SDS–PAGE gels, and transferred
to nitrocellulose membrane. IF1 (ab110277, Abcam), ATPsβ
(ab14730, Abcam), Calnexin (C4731, Sigma) and Vimentin
(V6630, Sigma) primary antibodies, and peroxidase-conjugated
anti-mouse (A5278, Sigma) and anti-rabbit (A6154, Sigma)
secondary antibodies were used for the immunoblotting assays.
Bands were visualized with enhanced chemiluminescence (ECL)
Western blotting substrates (ThermoScientific) and a ChemiDoc
XRS + molecular imaging system (Bio-Rad). The pixel
intensities of the bands were calculated using ImageLab
software.
Mitochondrial Membrane Potential
Measurements
A Zeiss 510 microscope (63× water immersion objective,
NA = 1.4) was used to record the 19m of pancreatic acinar,
PANC-1, MIA PaCa-2 and BxPC3 cells using TMRM. TMRM
has a delocalised positive charge and therefore accumulates in
the mitochondria due to its negative membrane potential with
respect to the cytosol. PDAC cell lines were seeded into 35 mm
glass-bottom dishes (MatTek) the day before the experiment.
PACs were isolated from the pancreas of a CD1 mouse on
the day of the experiment, and 120 µl of cell suspension was
seeded into glass-bottom dishes coated with Poly-L-lysine. The
acinar cells were then left in the dishes for approximately 30–
40 min, to allow attachment to the Poly-L-lysine coated glass
surface.
Before experiments all cell types were incubated in the
standard extracellular solution (see below) containing 40 nM
TMRM for 30 min. Glass-bottom dishes containing cells were
then placed onto the stage of an inverted confocal microscope and
connected to a gravity-fed perfusion system in order to apply the
specified extracellular solutions (see below). TMRM fluorescence
was excited using a 543nm laser line, and emission was collected
at wavelengths above 560 nm. Experiments were conducted at
approximately 30
◦
C. The confocal pinhole was set to 1.5 airy
units.
The ETC inhibitor Antimycin (5 µM), the F1F0-ATP synthase
inhibitor Oligomycin (5 µM), and the uncoupler CCCP (10 µM)
that were used in these experiments were diluted into the
standard extracellular solution, which was composed of 140 mM
NaCl, 10 mM Hepes, 4.7 mM KCl, 1.3 mM MgCl2, 1 mM CaCl2,
and 10 mM D-glucose. The solution was adjusted to pH 7.3
using NaOH. All extracellular solutions contained 40 nM of
TMRM.
ATP Measurements
For experiments with PDAC cell lines, 1ml of cell suspension
containing 30,000 PDAC cells in DMEM was seeded into the
individual wells of a 24-well plate the day before the experiment.
For experiments with PACs, 1ml of cell suspension containing
75,000 freshly isolated acinar cells was seeded into individual
wells of a 24-well plate 30–40 min before the experiment to
allow cell attachment. Experiments were conducted at 35
◦
C.
At the time of the experiment the cells were incubated in the
standard HEPES-based extracellular solution supplemented with
the specified inhibitors or with the corresponding vehicle controls
(0.05 or 0.1% ethanol). Following incubation, the extracellular
solutions were removed and 100 µl of ATP-releasing buffer
(FLSAR, Sigma) was added to each well. The plate was gently
rocked back and forth for 30 s to aid ATP-release. The ATP
assay kit (A22066, ThermoScientific) was used to measure
the concentration of ATP according to the manufacturer’s
instructions. This sensitive assay quantifies ATP by measuring
the bioluminescence of a solution after addition of luciferin and
luciferase. A POLARstar Omega plate reader (BMG Labtech)
was used to record bioluminescence [for further details see
(Armstrong et al., 2018)]. Changes in ATP were calculated
relative to the respective vehicle controls. An inhibitor mixture
of 5µm Antimycin, 5µm Oligomycin and 2mM Iodoacetate was
used as a positive control for the assay; this mixture results in
robust ATP depletion.
Cell Transfection
PANC-1 and MIA PaCa-2 cells were transfected with adenoviral
constructs (∼1 × 107 PFU/ml and ∼3 × 107 PFU/ml
respectively) containing either IF1 short hairpin (sh)RNA or
non-targeting (NT) shRNA (both from Vector Biolabs). After
transfection, cells were cultured for 96 h, to achieve > 75% IF1
knockdown, before usage in any functional experiments.
Knockout of IF1 in PANC-1 Cells
GenScript (NJ, United States) were recruited to create a
permanent biallelic knockout of the ATPIF1 gene in the PANC-1
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cell line using CRISPR/Cas9 genome editing. gRNA expression
plasmids, designed to target the ATPIF1 loci, were generated and
co-transfected into PANC-1 cells with cas9 expression plasmids.
Knockout efficiency in transfected cells was determined by Sanger
sequencing. Single cell clones with successful biallelic ATPIF1
knockout were generated. Knockout was confirmed using DNA
sequence confirmation and Western blot analysis. GenScript also
provided Wild-type (WT) PANC-1 cells that were used as the
respective PANC-1 controls for all experiments with IF1−/−
cells. Cell line authentication was carried out on the WT cells,
IF1−/− cells, and the PANC-1 cells obtained from ATCC to
verify that the identity of these cell lines were PANC-1.
Migration and Invasion Assays
Transwell cell migration and invasion assays were performed in
24-well plates with 8 µm pore cell culture inserts (Corning).
DMEM supplemented with 5% FBS was added to each well. For
the migration assays, PANC-1 cells (3× 104 per insert) and MIA
PaCa-2 cells (7.5 × 104 per insert) were seeded in serum-free
DMEM on top of the cell culture inserts and left to migrate over a
period of 16 h at 37◦C with 5% CO2 air in a humidified incubator.
Cotton buds were used to wipe the top of each membrane. The
migrated cells on the bottom of each membrane were fixed with
100% methanol, stained with propidium iodide, and imaged with
a 10x dry objective on an AOBS confocal microscope. Seven
representative images of each membrane were captured and Cell
Profiler software was used to count the migrated cells. For the
invasion assays, PANC-1 cells (4.5 × 104 per insert) and MIA
PaCa cells (1.2× 105 per insert) were seeded on top of 8 µm pore
cell culture inserts pre-coated with matrigel and left to invade for
a period of 24 h. The remaining procedure was the same as that
for the migration assay.
Proliferation Assays
Proliferation assays were performed in 35mm sterile cell culture
dishes. 20,000 cells were suspended in DMEM supplemented
with 10% FBS and seeded into two separate dishes. 4–5 h when
the cells had settled and adhered to the bottom of the plates,
20 representative images were captured for each dish using
a Zeiss 510 microscope and a 10× dry objective. The same
process was carried out on the dishes of cells 2 days later, and
percentage proliferation was calculated. A colorimetric assay
using the Cell counting kit-8 (NBS biologicals) was also used
as a second technique to measure proliferation, and was carried
out in accordance with the manufacturer’s instructions. Cells
were seeded into 96 well plates (5000 cells per well) and left
to proliferate for 48 hrs at 37◦C with 5% CO2 in a humidified
incubator. Cells were subsequently incubated with Cell counting
kit-8 solution for 1 h before absorbance was measured at 450 nm.
Statistical Analysis
Results are expressed as Mean± SEM. Significance was evaluated
with a Student’s t-test or one-way ANOVA followed by Dunnet’s
test and differences were considered significant when P < 0.05
(P < 0.05 is indicated by ∗ in the relevant figures).
RESULTS
The Distribution of IF1 and F1F0-ATP
Synthase in Human PDAC Sections
The expression of IF1 and F1F0-ATP synthase in human PDAC
tumor tissue sections was revealed by immunohistochemistry.
Tissue sections from 17 patients were stained for IF1
(representative images are shown in Figure 1) and the intensity
of antibody staining in different cell types was assessed by a
specialist histopathologist. Normal PACs demonstrated weak
cytoplasmic immunostaining with IF1 antibody compared to
moderately differentiated tumor epithelium which demonstrated
strong immunostaining (Figure 1A). IF1 immunostaining was
seen in inter- and intra-lobular ducts but was also weaker
than in cancerous tissue (Figure 1A). An example of PanIN-1
immunostaining is shown on the right panel of Figure 1A.
Two foci of PanIN-1 were identified in the tissue sections,
both revealing strong immunostaining. Poorly differentiated
tumor epithelium also demonstrated a high intensity of IF1
immunostaining compared to normal acinar cells within the
same tissue sections (Figure 1B). These results suggested that
IF1 expression increases during pancreatic carcinogenesis
and stimulated us to investigate IF1 expression and functions
in normal and malignant pancreatic cells. Lower panels of
Figure 1 show immunostaining with an antibody against the
ATPsβ. ATPsβ expression was present in all epithelial cell types
(Figure 1).
The IF1 and IF1/ATP Synthase Ratio in
Pancreas, Heart and Liver
Using immunoblotting we compared IF1 and ATPsβ levels in
lysates produced from mouse pancreas, heart and liver. We
observed that the degree of IF1 staining and, importantly,
the ratio of IF1 to its binding target, ATPsβ, differed
substantially between these organs. In these experiments the
heart was selected for comparison because cardiomyocytes
have particularly strong expression of IF1 (Campanella et al.,
2008). The 12- and 8-kDa isoforms of IF1 [(Sanchez-Arago
et al., 2013; Garcia-Bermudez and Cuezva, 2016) see also
GenBank: BC009677.1 and BC004955.1)] are clearly resolvable
in heart tissue (Figure 2A and Supplementary Figure 2).
Pancreas and liver tissue both demonstrated a significantly
lower expression level of IF1 relative to ATPsβ than the heart
tissue (Figures 2A,B and Supplementary Figure 2). Both 12-
and 8-kDa isoforms of IF1 were significantly less prominent
in pancreas and liver tissue (the liver allows comparison
with another major gland), with the 8-kDa isoform barely
detected.
The IF1 and IF1/ATP Synthase Ratio in
Pancreatic Acinar Cells and PDAC Cells
Immunofluorescence staining of the human pancreatic cancer
cell line, PANC-1, revealed that IF1 co-localizes with ATPsβ with
a Pearson coefficient of 92.0 ± 0.7% (n = 20) (Supplementary
Figure 3). This confirmed that IF1 is localized to the
mitochondria. With the intention of investigating the IF1/ATPsβ
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FIGURE 1 | IF1 and ATP synthase distribution in normal pancreas and PDAC. Immunohistochemical staining for IF1 and ATPsβ. Scale bars: 200 µm. (A) Tissue
sections from a patient with moderately differentiated (MD) PDAC. (B) Tissue sections from a patient with poorly differentiated (PD) PDAC. The figure demonstrates
that IF1 expression is higher in moderately and poorly differentiated cancer and PanIN-1 than normal ducts and acinar cells. ATP synthase staining is present in all
epithelial cell types. Note that for technical reasons, staining for IF1 and ATP synthase were conducted on neighboring tissue sections (approximately 5 µm apart).
Negative controls for immunohistochemical staining are shown in Supplementary Figure 1.
FIGURE 2 | Expression of IF1 and ATP synthase in mouse tissues.
(A) Western blot analysis shows expression of IF1 and ATPsβ in normal
mouse heart, pancreas and liver tissue (representative of 3 biological repeats).
Mouse heart tissue expresses the major 12- and 8-kDa protein isoforms of
IF1; the 12-kDa isoform of IF1 is resolvable in pancreas and liver. Full-length
blots are presented in Supplementary Figure 2. (B) The average IF1/ATPsβ
ratios were calculated for each tissue using the major 12-kDa IF1 isoform;
pancreas and liver tissue had a significantly lower IF1 and IF1/ATPsβ ratio than
the heart (n = 3).
ratio in normal acinar and PDAC cells, immunofluorescence
studies were then extended to include the human pancreatic
cancer cell line BxPC3, murine KPC-derived cells, and primary
PACs isolated from a CD1 mouse strain. The fluorescence
intensities of IF1 and ATPsβ were measured and used to calculate
the respective IF1/ATPsβ ratios in these cell types. This revealed
that the three pancreatic cancer cell lines, PANC-1, BxPC3
and KPC-derived cells, had a significantly higher IF1/ATPsβ
ratio than acinar cells isolated from healthy mouse pancreas
(Supplementary Figure 4).
Western blot analysis for IF1 and ATPsβ was carried out on
primary PACs isolated from CD1 and a C57BL6/J (B6) mice,
the human pancreatic ductal epithelial cell line (HPDE), the
human PDAC cell lines PANC-1, BxPC3, MIA PaCa-2 and on
KPC-derived cells (Figure 3A and Supplementary Figure 5).
These Western blots revealed that PACs isolated from a CD1 and
B6 mouse predominately express the 12-kDa isoform of IF1, in
contrast to the PDAC cell lines which almost exclusively express
the 8-kDa isoform of IF1 (Figures 3A–C and Supplementary
Figure 5). Ratios of the line intensities for individual isoforms
of IF1 to that of ATPsβ are shown on Figures 3B,C. The total
IF1/ATPsβ ratio, which includes the sum of line intensities for
both IF1 isoforms, was significantly higher in HPDE cells and
the pancreatic cancer cell lines than in PACs (Figure 3D). This
is consistent with the outcomes of immunostaining experiments
(see Figure 1).
Immediate early gene X-1 was reported to be involved in
the degradation of IF1 (Shen et al., 2009). In our study we also
observed a negative correlation between the IF1/ATPsβ ratio and
IEX-1 expression in the cell types tested. PACs isolated from
CD1 and B6 mice, which we have shown to have a low IF1/ATPs
ratio, demonstrated robust IEX-1 expression. The PDAC cell lines
PANC-1, BxPC3 and KPC-derived cells which have relatively
high IF1/ATPsβ ratios, demonstrated little to no IEX-1 expression
(Supplementary Figure 6).
Frontiers in Physiology | www.frontiersin.org 5 July 2018 | Volume 9 | Article 833
fphys-09-00833 July 9, 2018 Time: 15:29 # 6
Tanton et al. IF1 in Normal and Malignant Exocrine Pancreas
FIGURE 3 | Expression of IF1 and ATP synthase in pancreatic acinar cells, and pancreatic cancer cell lines. (A) Western blot analysis of IF1 and ATPsβ expression.
Pancreatic acinar cells (PAC) isolated from CD1 and C57BL/6 (B6) mice predominately express the 12-kDa protein isoform of IF1, whereas HPDE cells and the
pancreatic cancer cell lines PANC-1, MIA PaCa-2, BxPC3, and KPC-derived cells, predominately express the 8-kDa protein isoform of IF1. Calnexin is shown as a
loading control. Full-length blots are presented in Supplementary Figure 5. (B) Quantification of Western blot bands demonstrate that HPDE cells and the pancreatic
cancer cell lines have significantly higher levels of the 8-kDa IF1 isoform and higher 8-kDa IF1/ATPsβ ratios than pancreatic acinar cells (PAC) (n = 5).
(C) Quantification of Western blot bands demonstrate that HPDE cells and the pancreatic cancer cell lines have significantly lower levels of the 12-kDa IF1 isoform
and lower 12-kDa IF1/ATPsβ ratios than pancreatic acinar cells (PAC) (n = 5). (D) Combining the sum of the 12- and 8-kDa IF1 isoform band intensities
demonstrates that the HPDE cells and pancreatic cancer cell lines have significantly higher total IF1/ ATPsβ ratios than pancreatic acinar cells (PAC) (n = 5).
The IF1/ATP Synthase Ratio Determines
the Response of 19m to Mitochondrial
Inhibitors
By inhibiting the reverse mode of F1F0-ATP synthase, IF1
is expected to accelerate the dissipation of the 19m when
the ETC is inhibited (Campanella et al., 2008). To reveal
changes of 19m, cells were incubated with TMRM (fluorescent
probe with delocalised positive charge) (Voronina et al., 2004;
Campanella et al., 2008). The ETC inhibitor, antimycin, the
F1F0-ATP synthase inhibitor, oligomycin or a combination of
both inhibitors were used in these experiments. The ETC
uncoupler CCCP was added to the cells at the end of the
experiment to completely collapse 19m (Figures 4A,B). In
PACs, the rate of loss of 19m was substantially larger with the
addition of antimycin and oligomycin in combination, than with
the addition of antimycin alone (Figures 4A,C). The difference in
the rates was much smaller in BxPC3 and PANC-1 cells, which is
consistent with the high levels of IF1 in the mitochondria of these
cell types (Figures 4B,C).
We next tested the effect of reduction in IF1 expression on
19m responses. Immunoblotting was used to confirm that IF1
shRNA down-regulated the expression of IF1 in PANC-1 cells
(by 75–90%) compared to control cells transfected with NT
shRNA (Figure 4D left panel and Supplementary Figure 7A).
In these experiments the 19m changes in PANC-1 cells that
were transfected with NT shRNA (PANC-1 NT shRNA) or with
IF1 shRNA (PANC-1 IF1 shRNA) were compared. The 19m
changes in these cell types were recorded after application of
the same inhibitors. PANC-1 NT shRNA cells demonstrated very
similar responses to the inhibitors as PANC-1 cells (compare
Figures 4C,E). However, PANC-1 IF1 shRNA cells demonstrated
a larger difference in their normalized fluorescence changes when
antimycin and oligomycin were added in combination, than
when antimycin was added alone (Figure 4E).
Using IF1 knockout in PANC-1 cells we further investigated
the putative effect of IF1 on19m. Immunoblotting was also used
to confirm that IF1−/− PANC-1 cells did not demonstrate any
IF1 expression (see Figure 4D middle panel and Supplementary
Figure 7B). We compared 19m responses to mitochondrial
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FIGURE 4 | The response of the 19m to the addition of mitochondrial inhibitors in pancreatic acinar cells and pancreatic cancer cells. Oligomycin (O; green),
Antimycin (A; blue), or Antimycin + Oligomycin (A + O; red) and CCCP were utilized in these experiments. (A) Example traces of normalized TMRM fluorescence
recorded from pancreatic acinar cells (PAC) isolated from CD1 mice. (B) Example traces of normalized TMRM fluorescence recorded from PANC-1 cells. (C) The bar
graph summarizes the differences between the baseline TMRM fluorescence of the cells (PAC, PANC-1 and BxPC3), and their TMRM fluorescence recorded 75 s
after the addition of A or A + O. This difference reflects the rate of 19m dissipation (for PAC cells n = 27 for A and n = 12 for A + O; for PANC-1 cells n = 32 for A
and n = 21 for A + O; for BxPC3 cells n = 39 for A and n = 48 for A + O). (D) Western blot analysis of IF1 (8-kDa) in PANC-1 and MIA PaCa-2 cells. The left panel
illustrates efficiency of shRNA-mediated knockdown, whilst the middle panel demonstrates the complete IF1 knockout (by CRISPR/Cas9 gene editing) in PANC-1
cells. The right panel demonstrates efficiency of shRNA-mediated knockdown in MIA PaCa-2 cells. Full-length blots are presented in Supplementary Figure 7.
(E) The bar graph summarizes the differences between the baseline TMRM fluorescence of the cells and their TMRM fluorescence recorded 75 s after the addition of
A or A + O. This panel illustrates the difference in the rate of 19m dissipation in PANC-1 cells following transfection with non-targeting (NT) shRNA (n = 32 for A and
n = 21 for A + O) or IF1 shRNA (n = 25 for A and n = 20 for A + O). Similar changes were obtained for wild-type (WT) PANC-1 cells (n = 17 for A and n = 26 for
A + O) and IF1−/− PANC-1 cells (n = 8 for A and n = 10 for A + O). (F) The bar graph summarizes the differences between the baseline TMRM fluorescence of the
cells and their TMRM fluorescence recorded 75 s after the addition of A or A + O. This panel illustrates the difference in the rate of 19m dissipation in MIA PaCa-2
cells following transfection with NT shRNA (n = 8 for A and n = 18 for A + O) or IF1 shRNA (n = 16 for A and n = 17 for A + O).
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inhibitors of WT PANC-1 cells with those of IF1−/− PANC-1
cells (Figure 4E). We observed a significantly larger difference
between 19m responses to antimycin and the combination
of antimycin + oligomycin in IF1−/− PANC-1 than in WT
PANC-1 (Figure 4E). To investigate the effect of IF1 expression
on the 19m in an additional PDAC cell line, we compared
the 19m responses of MIA PaCa-2 cells transfected with
NT shRNA (MIA PaCa-2 NT shRNA) with those transfected
with IF1 shRNA (MIA PaCa-2 IF1 shRNA). Immunoblotting
was used to confirm that IF1 shRNA down-regulated the
expression of IF1 in MIA PaCa-2 cells (see Figure 4D right
panel and Supplementary Figure 7C). Similar to the results seen
in PANC-1 cells, we observed a significantly larger difference
between the 19m responses to antimycin and a combination of
antimycin+ oligomycin in IF1 shRNA MIA PaCa-2 cells than in
NT shRNA MIA PaCa-2 cells (Figure 4F).
The findings of these experiments are consistent with the
reported inhibitory action of IF1 on the reverse mode of F1F0-
ATP synthase (Campanella et al., 2008).
IF1 Levels and ATP Content in Cells
Subjected to Mitochondrial Inhibitors
Pancreatic acinar cells and PANC-1 cells were subjected to
20-min incubation with the following inhibitors; antimycin,
oligomycin, a combination of antimycin + oligomycin, and
iodoacetate (an inhibitor of glyceraldehyde-3-P-dehydrogenase).
PACs demonstrated large decreases (50–70%) in their ATP levels
in response to all inhibitors tested (Figure 5A), whilst PANC-1
cells only demonstrated a decrease in ATP levels in response to
iodoacetate (Figure 5A). This is compatible with the notion that
PACs have substantial oxidative and glycolytic components of
ATP production (Voronina et al., 2010), whilst PDAC cells are
largely glycolytic (James et al., 2015).
We next tested the effect of IF1 knockdown on the
bioenergetics of PANC-1 cells. PANC-1 cells transfected with
either NT or IF1 shRNA were also subjected to 20-min
incubation periods with antimycin, oligomycin, a combination
of antimycin + oligomycin or iodoacetate. In these experiments
we also used one extra inhibitor mixture which contained
antimycin, oligomycin and iodoacetate; this was applied as a
positive control for ATP depletion since both OXPHOS and
glycolysis are inhibited by the compounds present in this mixture.
The responses of PANC-1 cells transfected with NT shRNA were
very similar to those seen in PANC-1 cells that had not undergone
transfection. The responses of PANC-1 cells transfected with
IF1 shRNA were not drastically different to those of PANC-1
cells and PANC-1 cells transfected with NT shRNA (Figure 5B).
Antimycin caused a decrease in ATP levels in IF1 shRNA cells
compared to that of NT shRNA cells, (Figure 5B) but the
difference was not statistically significant (p = 0.07). There was
also no statistically significant difference between ATP levels
following antimycin and antimycin + oligomycin treatment of
IF1 shRNA cells (Figure 5B).
We were able to resolve the effect of IF1 knockout on the
bioenergetics of PANC-1 cells. Antimycin significantly reduced
ATP content in IF1−/− cells in comparison with the WT cells
FIGURE 5 | The effect of inhibitors of ATP production on ATP levels in
pancreatic acinar cells and PDAC cells (with normal, reduced or eliminated
IF1). ATP levels in the respective vehicle controls (control measurements) were
assumed to be 100% (left bars in A–D) and all measurements in individual cell
types were normalized to their corresponding controls (A–D). (A) To reveal the
effect of ETC, F1F0-ATP synthase and glycolysis inhibitors on ATP levels,
PANC-1 and pancreatic acinar cells (PAC) were incubated with Antimycin (A),
Oligomycin (O), Antimycin + Oligomycin (A + O), or Iodoacetate (IA) for 20 min
before ATP was extracted and measured (n = 6 for both cell types).
(B) PANC-1 cells transfected with NT or IF1 shRNA (n = 6 for both conditions)
were incubated with A, O, A + O, IA or A + O + IA for 20 min before ATP was
extracted and measured. (C) Wild-type (WT) and IF1 -/- PANC-1 cells were
incubated with A, O, A + O, IA or A + O + IA for 20 min before ATP was
extracted and measured. (D) MIA PaCa-2 cells transfected with NT or IF1
shRNA (n = 4 for both conditions) were incubated with A, O, A + O, IA, or
A + O + IA for 20 min before ATP was extracted and measured.
(Figure 5C) and there was a statistically significant difference
in ATP content of IF1−/− cells between the antimycin and
antimycin + oligomycin treatments. We next tested the effect
of IF1 knockdown on the bioenergetics of another PDAC cell
line MIA PaCa-2 and found modest (but statistically significant)
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FIGURE 6 | The effect of IF1 knockdown and knockout on proliferation, migration and invasion of pancreatic cancer cell lines. (A) Proliferation, determined using a
Cell counting kit-8 based assay. The percentage proliferation of PANC-1 cells transfected with IF1 shRNA was normalized to that of cells transfected with NT shRNA,
for each individual experiment (n = 3). The percentage proliferation of IF1−/− PANC-1 cells was normalized to that of WT PANC-1 cells for each individual
experiment (n = 3). The percentage proliferation of MIA PaCa-2 cells transfected with IF1 shRNA was normalized to that of cells transfected with NT shRNA for each
individual experiment (n = 3). (B) Cell migration, determined by the number of cells migrated through the porous membrane of Boyden chambers. The percentage
migration of PANC-1 cells transfected with IF1 shRNA was normalized to that of cells transfected with NT shRNA cells for each individual experiment (n = 4). The
percentage migration of IF1−/−PANC-1 cells was normalized to that of cells WT PANC-1 cells for each individual experiment (n = 4). The percentage migration of
MIA PaCa-2 cells transfected with IF1 shRNA was normalized to that of cells transfected with NT shRNA cells for each individual experiment (n = 3). Representative
images of propidium iodide stained cells on the outer surface of the Boyden chamber membrane are shown for each cell type. (C) Cell invasion, determined by the
number of cells that invaded through the porous membrane of matrigel-coated Boyden chamber. The percentage invasion of PANC-1 cells transfected with IF1
shRNA was normalized to that of cells transfected with NT shRNA cells for each individual experiment (n = 5). The percentage invasion of IF1−/−PANC-1 cells was
normalized to that of cells WT PANC-1 cells for each individual experiment (n = 4). The percentage invasion of MIA PaCa-2 cells transfected with IF1 shRNA was
normalized to that of cells transfected with NT shRNA cells for each individual experiment (n = 3).
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potentiation of the effect of antimycin (Figure 5D, compare
NT shRNA and IF1 shRNA cells). We did not however
find statistically significant difference in ATP content between
antimycin and antimycin + oligomycin treatments in MIA
PaCa-2 cells (Figure 5D). Both knockout and knockdown of IF1
in PANC-1 cells potentiated the effect of iodoacetate on ATP
levels (Figures 5B,C). Knockdown of IF1 in MIA PaCa-2 cells
also reduced the mean ATP content observed in the presence
of iodoacetate but the effect was not statistically significant
(Figure 5D). Overall, these results suggest that IF1 can modulate
ATP changes in PDAC cells, although the effects of IF1 were less
prominent than responses reported for some primary cell types
(e.g., Rouslin et al., 1990; Campanella et al., 2008).
Reduction or Removal of IF1 Decreases
Migration, Invasion and Proliferation of
PANC1 Cells
To investigate a putative functional role of IF1 in pancreatic
cancer, PANC-1 cells were transfected with NT shRNA or
IF1 shRNA and subsequently used in migration, invasion and
proliferation assays. WT PANC-1 cells and IF1−/− PANC-1
cells were also used in these assays, as well as MIA PaCa-2
cells transfected with NT shRNA or IF1 shRNA. Functional
assays demonstrated that IF1 knockdown significantly reduced
proliferation (Figure 6A and Supplementary Figure 8), migration
(Figure 6B), and invasion (Figure 6C) of PANC-1 cells and
MIA PaCa-2 cells compared to the corresponding NT shRNA
transfected control cells (Figures 6A–C). Similar decreases of
migration, invasion and proliferation were observed in IF1−/−
PANC-1 cells compared to WT controls (Figures 6A–C and
Supplementary Figure 8). Prominent changes in migration,
invasion and proliferation of PANC1 cells, attained as a result
of reduction or removal of IF1 suggest the importance of this
protein for growth and metastasis of PDAC tumors.
DISCUSSION
Some normal human tissues and cell types such as the
endometrium and kidney have a naturally high expression of IF1
(Sanchez-Arago et al., 2013). Neurons have a higher IF1/ATP
synthase ratio compared to astrocytes (Campanella et al., 2008).
Heart is another tissue type with high IF1 expression and a
high IF1/ ATP synthase ratio (Campanella et al., 2008) and was
used as a positive control in our study. We found that the
pancreas, of which more than 80% is composed of acinar cells
(Bolender, 1974), has relatively low IF1 and IF1/ATP synthase
ratio in comparison with the heart. The level of IF1 expression
appears to be dependent on the metabolic demand and glycolytic
potential of the particular tissue or cell type. Normal tissues
and cells that are highly metabolically active and do not have a
large glycolytic capacity, tend to have higher IF1/ATP synthase
ratios than those that have a lower metabolic demand and/or
the ability to efficiently use glycolysis for their ATP production
(Campanella et al., 2009). Pancreatic acinar cells have significant
glycolytic capacity (Voronina et al., 2010) therefore they can
FIGURE 7 | Summary figure. The figure illustrates the main finding of the
study that pancreatic acinar cells contain low IF1 levels and have a low IF1 to
ATP synthase ratio (symbol ‘R’ indicates ratio), whilst PDAC cells, which
probably originate as a result of malignant transformation of pancreatic acinar
cells, contain high levels of IF1 and have a high ratio of IF1 to ATP synthase.
There is also a notable change in the expression of IF1 isoforms; pancreatic
acinar cells preferentially express the 12-kDa isoform, whilst PDAC cells
preferentially express the 8-kDa isoform. The putative process of
transformation of the acinar cells to PDAC cells is indicated by the arrow.
probably afford to have relatively low IF1 levels, as observed in
our study.
Increased IF1 expression has been observed in a number
of cancers compared to corresponding normal cells and tissues
(Sanchez-Cenizo et al., 2010; Formentini et al., 2012; Sanchez-
Arago et al., 2013; Song et al., 2014; Wu et al., 2015; Yin et al.,
2015; Gao et al., 2016; Santacatterina et al., 2016). This increase
in IF1 expression accompanies and probably facilitates malignant
transformation (Sanchez-Cenizo et al., 2010; Formentini et al.,
2012; Song et al., 2014; Santacatterina et al., 2016). Our results
certainly indicate that PDAC belongs to this group of IF1-
enriched cancers. One of the mechanisms that can determine the
expression level of IF1 is IEX-1; this protein is considered to be
responsible for targeting IF1 for degradation by a mitochondrial
protease (Shen et al., 2009). In our study, strong IEX-1 expression
was observed in pancreatic acinar cells whilst IEX-1 levels
were low in all types of PDAC cells, demonstrating that IEX-
1 negatively correlated with IF1 expression. These findings are
consistent with the notion that IEX-1 is a regulator of IF1 levels.
The effects of IEX-1 and other putative mechanisms of IF1
regulation in pancreatic cells are beyond the remit of the current
study but will be further investigated in our laboratory.
Although controversial, there is reasonable evidence
indicating that PDAC develops as a result of malignant
transformation of pancreatic acinar cells [reviewed in (Rooman
and Real, 2012)]. Results of our study indicate that this process
is accompanied by an increase in IF1 content, an increase of
the IF1/ATPsβ ratio and interestingly, by the shift of the main
IF1 isoform; the 12-kDa isoform is preferentially expressed in
normal cells whilst the 8-kDa isoform is preferentially expressed
in PDAC cells (summarized in Figure 7). This prominent
isoform shift seems to be specific for pancreatic carcinogenesis.
It is important to note that increased IF1 expression in our
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study was also observed in HPDE cells, which is considered
to be a nontumorigenic cellular model of ductal epithelium
(Ouyang et al., 2000). This could indicate that an increase in IF1
levels accompanies early stages of acinar-to-ductal metaplasia
(the process that is likely to be important for pancreatic cancer
development (Rooman and Real, 2012; Storz, 2017). The high
levels of IF1 observed in PanINs are consistent with this notion.
The role of IF1 in acinar-to-ductal metaplasia and functions of
IF1 in pancreatic ducts, which are known to be susceptible to
mitochondrial damage in conditions of acute pancreatitis [(Biczo
et al., 2011; Maleth et al., 2011) reviewed in (Maleth and Hegyi,
2016)], are interesting subjects for further investigations.
Due to its effect on bioenergetics, increased IF1 expression can
increase the resilience of cancer cells, particularly in conditions
of hypoxia (Campanella et al., 2008; Sanchez-Cenizo et al.,
2010; Formentini et al., 2012). This is likely to be relevant
to PDAC, which is poorly vascularised (Koong et al., 2000;
Duffy et al., 2003; Kamphorst et al., 2015). The contribution
of IF1 to bioenergetics can be revealed by inhibiting the ETC
in the presence and absence of oligomycin. Oligomycin is a
pharmacological inhibitor of both the forward and reverse mode
of F1F0-ATP synthase, but in mitochondria with an inhibited
ETC, oligomycin can only suppress the reverse mode. The levels
of IF1 expression in different cell types appears to dictate the
degree of 19m preservation and ATP consumption when the
ETC is disrupted (Campanella et al., 2008). This is consistent
with our finding that the rate of 19m dissipation is slower in
cells with lower IF1 levels (PACs) than in cells with a higher
IF1 content (BxPC3 and PANC-1). Similarity of the rates of
19m dissipation in the presence and absence of F1F0-ATP
synthase inhibitor (oligomycin) suggests efficient IF1-mediated
inhibition of the reverse mode of F1F0-ATP synthase in PDAC
cells. Furthermore, in PANC-1 cells, both knockdown (using
specific shRNA) and knockout (using CRISPR/Cas9 gene editing)
of IF1 significantly increased the difference between the rates
of 19m dissipation in the presence and absence of F1F0-ATP
synthase inhibitor. Similar results were obtained with knockdown
of IF1 in MIA PaCa-2 cells. These experiments further confirm
the functional role of IF1.
The effects of IF1 knockdown in PANC-1 cells on the cytosolic
ATP content were less prominent than the effect on 19m
dissipation. A possible interpretation of these results is that
the remaining 20–25% of IF1 expression in IF1-shRNA treated
PDAC cells is able to sufficiently reduce ATP hydrolysis by the
reverse mode of F1F0-ATP synthase, making them difficult to
distinguish from the control cells. An alternative interpretation
is that the cells may accelerate their glycolytic ATP production
to compensate for the ATP consumption by F1F0-ATP synthase.
This interpretation is consistent with findings reported by
Fujikawa and colleagues (Fujikawa et al., 2012) in which HeLa
cells with knocked down IF1 expression demonstrated a relatively
small and transient reduction in ATP. Importantly, knockout
of IF1 in PANC-1 cells resulted in a statistically significant
reduction of ATP content in response to antimycin. Furthermore,
the addition of oligomycin (in combination with antimycin)
partially reversed this effect. Knockdown of IF1 in MIA PaCa-2
cells resulted in modest but statistically significant reduction
in ATP content following antimycin treatment (in comparison
with control NT shRNA treated cells). Taken together, these
results indicate that IF1 contributes to the bioenergetics and
mitochondrial metabolism of PDAC cells, particularly when the
ETC is inhibited (which can occur in conditions of hypoxia).
In addition to its effect on cellular bioenergetics, IF1 was
reported to modify the proliferation (Formentini et al., 2012;
Sanchez-Arago et al., 2013; Yin et al., 2015; Santacatterina et al.,
2016), migration and invasion (Formentini et al., 2012; Song
et al., 2014; Wu et al., 2015; Yin et al., 2015) of cancer cells. In our
experiments, both knockdown and knockout of IF1 in PANC-1
cells, and knockdown of IF1 in MIA PaCa-2 cells, produced a
statistically significant reduction in the proliferation of PANC-
1 cells. Knockdown and knockout of IF1 both demonstrated
prominent reductions in the migration and invasion of PANC-
1 cells. Knockdown of IF1 also reduced migration and invasion
of MIA PaCa-2 cells. Previous studies have linked IF1-mediated
changes in migration and invasion, with a shift between the
mesenchymal and epithelial phenotype of cancer cells (Song et al.,
2014; Wu et al., 2015). In our study we were not able to resolve
differences in the expression of mesenchymal marker (Vimentin)
between PANC-1 cells and cells with reduced or eliminated IF1
(not shown, n = 3 for both knockdown and knockout). The
relationship between IF1 and the migration/invasion of PDAC
cells is therefore still enigmatic and constitutes the subject of
further investigations in our laboratory.
This study reports low IF1 levels in normal acinar cells
and high IF1 levels in pancreatic cancer cells suggesting that
its expression increases during pancreatic carcinogenesis. Our
results also indicate the importance of IF1 for bioenergetics,
proliferation, migration and invasion of PDAC cells, suggesting
its relevance for the growth and dissemination of PDAC.
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